Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Chugai discloses erythromycins for gastrointestinal disorders

Nov. 27, 1996

Japanese researchers describe orally active antihypertensive agents

Nov. 27, 1996

New NO inhibitors disclosed by Fujisawa

Nov. 27, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

New antioxidant from Shiseido shows CNS activity

Nov. 27, 1996

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Lilly claims 5-HT7 antagonist for GI indications

Nov. 26, 1996

HMG-CoA reductase inhibitors for preventing second heart attack

Nov. 26, 1996

Neuregulin polypeptides described for treating retinal disorders

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...